Basic study and phase I clinic trial of anti-idiotypic antibody mimicking nasopharyngeal carcinoma cell antigen
An anti-idiotypic monoclonal antibody 2A9 (Ab2) was prepared, which mimicked the nasopharynegeal carcinoma (NPC) cell antigen defined by anti-NPC McAb Fcl. The abilities of 2A9’s inducing humoral and cellular immunity against NPC cell antigen were studied in syngeneic mice by inducing anti-Ab2 sera (Ab3) and delayed-type hypersensitivity. Two periods of phase 1 clinical trials were carried out, stage IV NPC patients receiving radiotherapy were chosen. Human anti-mouse antibodies (HAMA), anti-anti-idiotypic antibodies (Ab3), and anti-NPC cell antibodies (Abl′) were detected by ELISA. TNF-α,IL-2, IFN-γ levels in sera were determined by ELISA Kits. IL-2 mRNA expression in peripheral blood mononuclear cells (PBMC) were shown byin situ hybridization. The results showed that 2A9 was safe in applying on NPC patients and induced some humoral and/or cellular immune responses.
Key wordsNPC Anti-idiotypic McAb Clinical trial
Unable to display preview. Download preview PDF.
- 1.Mittleman A, Chen ZJ, Kageshita T, et al. Active specific immunotherapy in patients with melanoma-A clinical trial with mouse antiidiotypic monoclonal antibodies elicited with syngeneic anti-high-molecular-weight-melanoma-associated antigen monoclonal antibodies. J Clin Invest 1990; 86:2136.CrossRefGoogle Scholar
- 2.Mittleman A, Chen ZJ, Hong Y, et al. Human high molecular-weight melanoma-associated antigen (HMW-MAA) mimicry by mouse anti-idiotypic monoclonal antibody MK 2-23: induction of humoral anti-HMW-MAA immunity and prolongation of survival in patients with stage IV melanoma. Proc Natl Acad Sci USA 1992; 89:466.CrossRefGoogle Scholar
- 7.Wu ZY, Ling SZ, Wang ZQ, et al. Otolaryngology. Gui Yang: Science and Technology Press of Guizhou, 1992; 213Google Scholar
- 9.Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A laboratory manual, 2nd ed. United States of America: Cold Spring Harbor Laboratory Press, 1989; 1.21.Google Scholar